Stress Incontinence clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
Sorry, in progress, not accepting new patients
This study evaluates the efficacy and safety of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR; generic name: iltamiocel) compared to a placebo in the reduction of stress incontinence episode frequency in adult female patients with post-surgical persistent or recurrent stress urinary incontinence (SUI). Half of the participants will receive AMDC-USR (injections with cells) and the other half will receive placebo.
Los Angeles, California and other locations
Our lead scientists for Stress Incontinence research studies include Christopher M. Tarnay, MD, MHA.
Last updated: